← Back to Patent Explorer
US4479793A Expired / Lapsed US ⏱️ 0.0 years remaining

Parenteral administration using drug delivery device

Assignee: Alza Corp
•
Filing: 1983-10-11
•
Granted: 1984-10-30
•
Expires: 2003-10-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A parenteral delivery system is disclosed for administering a beneficial agent to a recipient. The system comprises (a) a container of a medical fluid; (b) a primary tubing in communication with the container; (c) a parallel tubing connected to the primary tubing having a formulation chamber connected thereto, the formulation chamber housing a beneficial agent, or a device for delivering a beneficial agent; and (d) a common tubing connected to the primary tubing and the parallel tubing for administering the fluid and the agent to a recipient.

Inventors

  • 👤 John Urquhart
  • 👤 Felix Theeuwes

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 06:25
CPC Classifications
A; A61; A61M; A61M5/00; A61M5/14; A61M5/1407; A61M5/1409; A61M5/142; A61M5/145; A61M2005/14513

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 190 words
An administration set for use with a parenteral therapeutic system, the administration set comprising: (a) a primary tube for the flow of a medical fluid therethrough; (b) a parallel tube in fluid communication with the primary tube for the flow of medical fluid therethrough; and, (c) a drug formulation chamber in the parallel tube, the chamber comprising; (1) a wall surrounding a space; (2) an inlet in the wall that communicates with the parallel tube for receiving fluid into the chamber; (3) a drug delivery device in the chamber, said device comprising a wall formed of a microporous material that substantially surrounds a solid reservoir containing a dosage unit amount of a beneficial drug that forms on its release from the device a drug formulation with fluid that enters the chamber and wherein, when the administration set is in operation and administering drug to a recipient, a beneficially effective amount of the drug is administered by the combined operations of the device releasing drug and the rate of fluid flow through the chamber; and, (4) an outlet in the wall for the flow of fluid containing drug from the chamber.
Claim 2
Dependent Claim 190 words
An administration set for use with a parenteral therapeutic system, the administration set comprising: (a) a primary tube for the flow of a medical fluid therethrough; (b) a parallel tube in fluid communication with the primary tube for the flow of medical fluid therethrough; and, (c) a drug formulation chamber in the parallel tube, the chamber comprising; (1) a wall surrounding a space; (2) an inlet in the wall that communicates with the parallel tube for receiving fluid into the chamber; (3) a drug delivery device in the chamber, said device comprising a wall formed of a microporous material that substantially surrounds a solid reservoir containing a dosage unit amount of a beneficial drug that forms on its release from the device a drug formulation with fluid that enters the chamber and wherein, when the administration set is in operation and administering drug to a recipient, a beneficially effective amount of the drug is administered by the combined operations of the device releasing drug and the rate of fluid flow through the chamber; and, (4) an outlet in the wall for the flow of fluid containing drug from the chamber.
Claim 3
Dependent Claim 187 words
An administration set for use with a parenteral therapeutic system, the administration set comprising: (a) a primary tube for the flow of a medical fluid therethrough; (b) a parallel tube in fluid communication with the primary tube for the flow of the medical fluid therethrough; and, (c) a drug formulation chamber connected to the parallel tube, the chamber comprising: (1) a wall surrounding a lumen; (2) an inlet in the wall that communicates with the parallel tube for receiving a fluid that flows into the chamber; (3) a drug delivery device in the chamber, the device comprising a matrix formed of a microporous material containing a dosage amount of a beneficial drug that forms on its release from the device a drug formulation with fluid that enters the chamber and wherein, when the administration set is in operation and administering drug to a recipient, a beneficially effective amount of the drug is administered by the combined operations of the device releasing drug and the rate of fluid flow through the chamber; and, (4) an outlet in wall for the flow of fluid containing drug from the chamber.
Claim 4
Dependent Claim 187 words
An administration set for use with a parenteral therapeutic system, the administration set comprising: (a) a primary tube for the flow of a medical fluid therethrough; (b) a parallel tube in fluid communication with the primary tube for the flow of the medical fluid therethrough; and, (c) a drug formulation chamber connected to the parallel tube, the chamber comprising: (1) a wall surrounding a lumen; (2) an inlet in the wall that communicates with the parallel tube for receiving a fluid that flows into the chamber; (3) a drug delivery device in the chamber, the device comprising a matrix formed of a microporous material containing a dosage amount of a beneficial drug that forms on its release from the device a drug formulation with fluid that enters the chamber and wherein, when the administration set is in operation and administering drug to a recipient, a beneficially effective amount of the drug is administered by the combined operations of the device releasing drug and the rate of fluid flow through the chamber; and, (4) an outlet in wall for the flow of fluid containing drug from the chamber.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-10-30 1988-04-30 1988-10-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-10-30 1992-04-30 1992-10-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-10-30 1996-04-30 1996-10-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag